Citius Oncology, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CTOR Company Description
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
CTOR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CTOR Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CTOR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CTOR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of CTOR in WallStreetBets Daily Discussion
CTOR News
Recent insights relating to CTOR
CNBC Recommendations
Recent picks made for CTOR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CTOR
Corporate Flights
Flights by private jets registered to CTOR
Our Analysis